Study on the usefulness of high-molecular-weight (HMW)-Adiponectin level check of Japanese general population upon health check: Comparison of carotid ultrasonography measurement

Clinical Biochemistry

Volumn 45, Issue 1-2, 2012, Pages 72-76

  Komatsu, Junko ^a   Fujiwara, Mutsunori ^a   Matsuura, Masaaki ^b   Ito, Satoru ^c   Oritsu, Masae ^a  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^b CANCER INSTITUTE   (Japan)

^c FUJIREBIO INC   (Japan)

Author keywords

Carotid ultrasonography; CLEIA; Health Check up; HMW adiponectin

Indexed keywords

ADIPONECTIN; HIGH MOLECULAR WEIGHT ADIPONECTIN; UNCLASSIFIED DRUG;

ADIPONECTIN BLOOD LEVEL; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERIOGRAPHY; CAROTID ULTRASONOGRAPHY; CHEMILUMINESCENT ENZYME IMMUNOASSAY; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HUMAN; JAPAN; JAPANESE; LABORATORY AUTOMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC PARAMETERS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; UNIVERSITY HOSPITAL;

ABDOMINAL FAT; ADIPONECTIN; AGE FACTORS; AGED; ATHEROSCLEROSIS; AUTOMATION; CAROTID ARTERIES; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MOLECULAR WEIGHT; REFERENCE VALUES; REGRESSION ANALYSIS; RISK ASSESSMENT; SEX FACTORS; ULTRASONOGRAPHY;

EID: 84855302443     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.10.013     Document Type: Article

References (33)

1. Snijder M.B., Heine R.J., Seidell J.C., Bouter L.M., Stehouwer C.D., Nijpels G., et al. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study. Diabetes Care 2006, 29:2498-2503.
2. Mather K.J., Funahashi T., Matsuzawa Y., Edelstein S., Bray G.A., Kahn S.E., et al. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes 2008, 57:980-986.
3. Waki H., Yamauchi T., Kamon J., Ito Y., Uchida S., Kita S., et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003, 278:40352-40363.
4. Wang Y., Lam K.S., Chan L., Chan K.W., Lam J.B., Lam M.C., et al. Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex. J Biol Chem 2006, 281:16391-16400.
5. Aso Y., Yamamoto R., Wakabayashi S., Uchida T., Takayanagi K., Takebayashi K., et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 2006, 55:1954-1960.
6. Inoue T., Kotooka N., Morooka T., Komoda H., Uchida T., Aso Y., et al. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Am J Cardiol 2007, 100:569-574.
7. Nakano Y., Tajima S., Yoshimi A., Akiyama H., Tsushima M., Tanioka T., et al. A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin. J Lipid Res 2006, 47:1572-1582.
8. Tanita T., Miyakoshi H., Nakano Y. Performance of ELISA for specific measurement of high-molecular-weight (HMW) adiponectin. J Immunol Methods 2008, 333:139-146.
9. Hayama S., Higuchi T., Miyakoshi H., Nakano Y. Analytical evaluation of a high-molecular-weight (HMW) adiponectin chemiluminescent enzyme immunoassay. Clin Chim Acta 2010, 411:2073-2078.
10. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 291:1730-1737.
11. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941-946.
12. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006, 116:1784-1792.
13. Asterholm I.W., Scherer P.E. Enhanced metabolic flexibility associated with elevated adiponectin levels. Am J Pathol 2010, 176:1364-1376.
14. Mori I., Ishizuka T., Morita H., Matsumoto M., Uno Y., Kajita K., et al. Comparison of biochemical data, blood pressure and physical activity between longevity and non-longevity districts in Japan. Circ J 2008, 72:1680-1684.
15. Kobayashi H., Ouchi N., Kihara S., Walsh K., Kumada M., Abe Y., et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004, 94:e27-e31.
16. von Eynatten M., Humpert P.M., Bluemm A., Lepper P.M., Hamann A., Allolio B., et al. High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men. Atherosclerosis 2008, 199:123-128.
17. Seino Y., Hirose H., Saito I., Itoh H. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men. Metabolism 2009, 58:355-360.
18. Hara K., Horikoshi M., Yamauchi T., Yago H., Miyazaki O., Ebinuma H., et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006, 29:1357-1362.
19. Denzel M.S., Scimia M.C., Zumstein P.M., Walsh K., Ruiz-Lozano P., Ranscht B. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest 2010, 120:4342-4352.
20. Uchida T., Shimizu M., Sakai Y., Nakano T., Hara K., Takebayashi K., et al. Effects of losartan on serum total and high-molecular weight adiponectin concentrations in hypertensive patients with metabolic syndrome. Metabolism 2008, 57:1278-1285.
21. Phillips S.A., Kung J., Ciaraldi T.P., Choe C., Christiansen L., Mudaliar S., et al. Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans. Am J Physiol Endocrinol Metab 2009, 297:E767-E773.
22. Fujimatsu D., Kotooka N., Inoue T., Nishiyama M., Node K. Association between high molecular weight adiponectin levels and metabolic parameters. J Atheroscler Thromb 2009, 16:553-559.
23. Combs T.P., Berg A.H., Rajala M.W., Klebanov S., Iyengar P., Jimenez-Chillaron J.C., et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003, 52:268-276.
24. Xu A., Chan K.W., Hoo R.L., Wang Y., Tan K.C., Zhang J., et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 2005, 280:18073-18080.
25. Akishita M., Fukai S., Hashimoto M., Kameyama Y., Nomura K., Nakamura T., et al. Association of low testosterone with metabolic syndrome and its components in middle-aged Japanese men. Hypertens Res 2010, 33:587-591.
26. Yasui T., Tomita J., Miyatani Y., Yamada M., Uemura H., Irahara M., et al. Associations of adiponectin with sex hormone-binding globulin levels in aging male and female populations. Clin Chim Acta 2007, 386:69-75.
27. Andersen K.K., Frystyk J., Wolthers O.D., Heuck C., Flyvbjerg A. Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children. J Clin Endocrinol Metab 2007, 92:1857-1862.
28. Wang C., Jackson G., Jones T.H., Matsumoto A.M., Nehra A., Perelman M.A., et al. Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care 2011, 34:1669-1675.
29. Miyatani Y., Yasui T., Uemura H., Yamada M., Matsuzaki T., Kuwahara A., et al. Associations of circulating adiponectin with estradiol and monocyte chemotactic protein-1 in postmenopausal women. Menopause 2008, 15:536-541.
30. Handa N., Matsumoto M., Maeda H., Hougaku H., Kamada T. Ischemic stroke events and carotid atherosclerosis. Results of the Osaka Follow-up Study for Ultrasonographic Assessment of Carotid Atherosclerosis. Stroke 1995, 26:1781-1786.
31. Sakaguchi M., Kitagawa K., Nagai Y., Yamagami H., Kondo K., Matsushita K., et al. Equivalence of plaque score and intima-media thickness of carotid ultrasonography for predicting severe coronary artery lesion. Ultrasound Med Biol 2003, 29:367-371.
32. Tsushima M., Terayama Y., Momose A., Funyu T., Ohyama C. Progression of atherosclerosis in hemodialysis patients: effect of adiponectin on carotid intima media thickness. J Atheroscler Thromb 2008, 15:213-218.
33. Rosengren A., Wedel H., Wilhelmsen L. Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J 1999, 20:269-277.